Sheerin Dylan, Openshaw Peter Jm, Pollard Andrew J
Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
the NIHR Oxford Biomedical Research Centre.
Eur J Immunol. 2017 Dec;47(12):2017-2025. doi: 10.1002/eji.201746942. Epub 2017 Sep 27.
Vaccination is a principal and highly cost-effective means of controlling infectious diseases, providing direct protection against pathogens by conferring long-lasting immunological memory and inducing population-level herd immunity. Despite rapid ongoing progress in vaccinology, there remain many obstacles to the development and deployment of novel or improved vaccines; these include the underlying science of how to induce and sustain appropriate protective immune responses as well as bureaucratic, logistic and socio-political hurdles. The failure to distribute and administer existing vaccines to at-risk communities continues to account for a large proportion of infant mortality worldwide: almost 20 million children do not have access to basic vaccines and several million still die each year as a result. While emerging epidemic or pandemic diseases pose a significant threat to global health and prosperity, there are many infectious diseases which provide a continuous or cyclical burden on healthcare systems which also need to be addressed. Gaps in knowledge of the human immune system stand in the way of developing technologies to overcome individual and pathogenic variation. The challenges in tackling infectious disease and directions that the field of preventive medicine may take to improve the current picture of global health are the focus of this review.
疫苗接种是控制传染病的主要且极具成本效益的手段,通过赋予持久的免疫记忆和诱导群体水平的 herd 免疫来直接抵御病原体。尽管疫苗学领域目前正在迅速取得进展,但新型或改良疫苗的研发和推广仍存在许多障碍;这些障碍包括如何诱导和维持适当的保护性免疫反应的基础科学,以及官僚、后勤和社会政治方面的障碍。未能将现有疫苗分发和接种到高危社区,仍然是全球婴儿死亡的很大一部分原因:近 2000 万儿童无法获得基本疫苗,每年仍有数百万人因此死亡。虽然新出现的流行病或大流行病对全球健康和繁荣构成重大威胁,但许多传染病也给医疗系统带来持续或周期性负担,也需要加以应对。人类免疫系统知识的空白阻碍了开发克服个体和病原体变异的技术。应对传染病的挑战以及预防医学领域为改善当前全球健康状况可能采取的方向是本综述的重点。